• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2011 Fiscal Year Final Research Report

The determination of the hSNF5 target genes and the clarification of the transcriptional mechanism of hSNF5

Research Project

  • PDF
Project/Area Number 22890157
Research Category

Grant-in-Aid for Research Activity Start-up

Allocation TypeSingle-year Grants
Research Field Pediatrics
Research InstitutionKyoto Prefectural University of Medicine

Principal Investigator

KUWAHARA Yasumichi  京都府立医科大学, 医学研究科, 助教 (30590327)

Project Period (FY) 2010 – 2011
Keywordsラブドイド腫瘍 / hSNF5 / NOXA
Research Abstract

Malignant rhabdoid tumor(MRT), a highly aggressive cancer of young children, displays inactivation of the hSNF5 gene in primary tumors and cell lines. We have previously reported that reexpression of hSNF5 in MRT cell lines causes a G1 arrest via p21WAF1/CIP1(p21) mRNA induction. However, the mechanisms of p21 promoter activation by hSNF5 remain unclear.
Because p21 is a transcriptional target of the p53 tumor suppressor gene, we determined the role of p53 in hSNF5-induced p21 activation. We reexpressed hSNF5 in the A204 and TTC642 MRT cell lines, with or without stable knockdown of p53 expression, using adenoviral vectors expressing either hSNF5 and GFP or GFP. While loss of p53 expression significantly inhibited p21 transcriptional activity induced by hSNF5 in A204 cells at 24 hours, it did not alter its activity by hSNF5 after 24 hours in the TTC642 cells. These results suggested that the up-regulation p21 transcription by hSNF5 operated through p53-dependent and. independent mechani … More sms in the A204 and TTC642 cell lines, respectively. Next, we used chromatin immunoprecipitation(ChIP) analysis of the p21 promoter to determine where hSNF5 appeared at the p21 promoter and whether its recruitment altered binding of other transcription factors or the chromatin landscape. Our results indicated that reexpressed hSNF5 binds within 1 kb of transcript start site(TSS), with maximal enrichment at the TSS in both cell lines. Furthermore, histone acetyltransferases(HATs), RNA polymerase II(RNAPII), and BRG-1 are assembled with p53 and CDK8(co-activator of p53 transcriptional program) by reexpression of hSNF5 in A204 cells. In contrast, while p53 and CDK8 occupancy did not change after hSNF5 reexpression in the TTC642 cells, HATs, RNAPII, and BRG-1 levels increased at the p21 promoter. These findings correlated with the results of p53 knock-down experiments. Furthermore, histone H3K36 tri-methylation increased downstream of the TSS in both cell lines. These results suggested hSNF5 regulates the initiation activity of the p21 promoter by either itself or p53 recruitment, resulting in the mRNA elongation.
Our findings demonstrate that while induction of p21 transcription by hSNF5 in A204 cells depends on p53, it occurs independently of p53 in TTC642 cells. The lack of dependence upon p53 appears to extend to other MRT cell lines tested in our laboratory. Furthermore, our results suggest that hSNF5 may alter p21 transcriptional initiation by itself or through the recruitment of other uncharacterized transcription factors. Less

  • Research Products

    (7 results)

All 2012 2011 2010

All Journal Article (1 results) Presentation (6 results)

  • [Journal Article] Sensitivity of malignant rhabdoid tumor cell lines to PD0332991 is inverserly correlated with p16 expression2011

    • Author(s)
      Katsumi Y, Iehara T, Miyachi M, Yagyu Y, Tsubai-Shimizu T, Kikuchi K, Tamura S, Itoh H, Kuwahara Y, Tsuchiya K, Kuroda H, Sugimoto T, Houghton PJ, Hosoi H
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 413 Pages: 62-68

  • [Presentation] Malignant Rhabdoid Tumor(悪性ラブドイド腫瘍: MRT)の最新治療と今後の課題:COG、EUの現況をふまえて2012

    • Author(s)
      〓原康通, 勝見良樹、土屋邦彦、家原知子、細井創
    • Organizer
      平成23年度日本ウィルムス腫瘍スタディ(JWiTS)研究会
    • Place of Presentation
      東京
    • Year and Date
      20120100
  • [Presentation] 悪性ラブドイド腫瘍細胞株におけるhSNF5によるp53標的遺伝子の発現制御のメカニズム2011

    • Author(s)
      〓原康通, Bernard Weissman、細井創
    • Organizer
      第53回日本小児血液・がん学会学術集会
    • Place of Presentation
      前橋
    • Year and Date
      20111100
  • [Presentation] hSNF5はp53依存性機序とp53非依存性機序でp21の転写を制御する2011

    • Author(s)
      〓原康通, Bernard Weissman、細井創
    • Organizer
      第5回日本エピジェネティック研究会年会
    • Place of Presentation
      熊本
    • Year and Date
      20110500
  • [Presentation] Reexpression of hSNF5 regulates the transcriptional activity of the p21 promoter through p53 dependent or independent mechanisms in malignant rhabdoid tumors2011

    • Author(s)
      Kuwahara Y, Durand J
    • Organizer
      Weissman BE 102th American Association for Cancer Research Annual Meeting
    • Place of Presentation
      Orlando, Florida
    • Year and Date
      20110400
  • [Presentation] 悪性ラブドイド腫瘍細胞株におけるhSNF5によるp53標的遺伝子の発現制御2011

    • Author(s)
      〓原康通, Bernard Weissman、細井創
    • Organizer
      平成22年度日本ウィルムス腫瘍スタディ(JWiTS)研究会
    • Place of Presentation
      東京
    • Year and Date
      20110100
  • [Presentation] 悪性ラブドイド腫瘍細胞株においてhSN F5はp21を介して細胞周期を制御する2010

    • Author(s)
      〓原康通, Bernard Weissman、細井創
    • Organizer
      第26回日本小児がん学会学術集会
    • Place of Presentation
      大阪
    • Year and Date
      20101200

URL: 

Published: 2013-07-31  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi